Works matching AU He, Dong-Yi

Results: 7

IL-18 Upregulates the Production of Key Regulators of Osteoclastogenesis from Fibroblast-Like Synoviocytes in Rheumatoid Arthritis.

Published in:

Inflammation, 2013, v. 36, n. 1, p. 103, doi. 10.1007/s10753-012-9524-8

By:

Zhang, Wei;
Cong, Xiao-Liang;
Qin, Yang-Hua;
He, Zheng-Wen;
He, Dong-Yi;
Dai, Sheng-Ming

Publication type:

Article

Rapid Onset of Efficacy of Baricitinib in Chinese Patients with Moderate to Severe Rheumatoid Arthritis: Results from Study RA-BALANCE.

Published in:

Advances in Therapy, 2021, v. 38, n. 1, p. 772, doi. 10.1007/s12325-020-01572-y

By:

Li, Zhan-Guo;
Hu, Jian-Kang;
Li, Xiang-Pei;
Yang, Yue;
Li, Xing-Fu;
Xu, Jian-Hua;
Zhang, Xiao;
Xu, Jian;
Bao, Chun-De;
He, Dong-Yi;
Li, Zhi-Jun;
Wang, Guo-Chun;
Zuo, Xiao-Xia;
Liu, Yi;
Xiao, Zheng-Yu;
Chen, Jin-Wei;
Xin, Xia-Fei;
Li, Jing-Yang;
Jiang, Lin-Di;
Liu, Meng-Ru

Publication type:

Article

The effects of dopamine receptor 2 expression on B cells on bone metabolism and TNF-α levels in rheumatoid arthritis.

Published in:

2016

By:

Lei Wei;
Ying Sun;
Xiu-Fang Kong;
Chi Zhang;
Tao Yue;
Qi Zhu;
Dong-Yi He;
Lin-Di Jiang;
Wei, Lei;
Sun, Ying;
Kong, Xiu-Fang;
Zhang, Chi;
Yue, Tao;
Zhu, Qi;
He, Dong-Yi;
Jiang, Lin-Di

Publication type:

journal article

Glucocorticoid Discontinuation in Patients with Rheumatoid Arthritis under Background of Chinese Medicine: Challenges and Potentials Coexist.

Published in:

Chinese Journal of Integrative Medicine, 2025, v. 31, n. 7, p. 581, doi. 10.1007/s11655-025-4212-3

By:

Yao, Chuan-hui;
Zhang, Chi;
Song, Meng-ge;
Xia, Cong-min;
Chang, Tian;
Ma, Xie-li;
Liu, Wei-xiang;
Liu, Zi-xia;
Liu, Jia-meng;
Tang, Xiao-po;
Liu, Ying;
Liu, Jian;
Peng, Jiang-yun;
He, Dong-yi;
Huang, Qing-chun;
Gao, Ming-li;
Yu, Jian-ping;
Liu, Wei;
Zhang, Jian-yong;
Zhu, Yue-lan

Publication type:

Article

Traditional Chinese Medicine Qingre Huoxue Treatment vs. the Combination of Methotrexate and Hydroxychloroquine for Active Rheumatoid Arthritis: A Multicenter, Double-Blind, Randomized Controlled Trial.

Published in:

Frontiers in Pharmacology, 2021, v. 11, p. 1, doi. 10.3389/fphar.2021.679588

By:

Gong, Xun;
Liu, Wei-Xiang;
Tang, Xiao-Po;
Wang, Jian;
Liu, Jian;
Huang, Qing-Chun;
Liu, Wei;
Fang, Yong-Fei;
He, Dong-Yi;
Liu, Ying;
Gao, Ming-Li;
Wu, Qing-Jun;
Chen, Shi;
Li, Zhen-Bin;
Wang, Yue;
Xie, Yan-Ming;
Zhang, Jun-Li;
Zhou, Cai-Yun;
Ma, Li;
Wang, Xin-Chang

Publication type:

Article

Efficacy and Safety of Baricitinib in Chinese Rheumatoid Arthritis Patients and the Subgroup Analyses: Results from Study RA-BALANCE.

Published in:

Rheumatology & Therapy, 2020, v. 7, n. 4, p. 851, doi. 10.1007/s40744-020-00231-6

By:

Yang, Yue;
Li, Xing-Fu;
Zhang, Xiao;
Bao, Chun-De;
Hu, Jian-Kang;
Xu, Jian-Hua;
Li, Xiang-Pei;
Xu, Jian;
He, Dong-Yi;
Li, Zhi-Jun;
Wang, Guo-Chun;
Wu, Han-Jun;
Ji, Fei;
Zhan, Lu-Jing;
Zerbini, Cristiano A. F.;
Li, Zhan-Guo

Publication type:

Article

Good response to infliximab in rheumatoid arthritis following failure of interleukin-1 receptor antagonist.

Published in:

International Journal of Rheumatic Diseases, 2016, v. 19, n. 4, p. 370, doi. 10.1111/1756-185X.12387

By:

Bao, Jun;
Yue, Tao;
Li, Ting;
He, Dong‐Yi;
Bao, Yi‐Xiao

Publication type:

Article